CAR-KHYG-1 cells have been able to selectively eliminate glioblastoma cells, thus demonstrating that AXL, c-Met and FORL1 can be very valuable therapeutic targets to counteract glioblastoma [90]. This evidence concerns the gene MET and glioblastoma.